MITF and melanoma: Given that MITF controls many aspects of melanoma biology [22], including expression of differentiation-associated antigens such as MLANA [31], microenvironmental stresses that lead to low MITF expression are associated with resistance to conventional T-cell based immunotherapies, despite their frequently high levels of T-cell infiltration [11].